Jacob B Allred Selected Research

Jacob B Allred Research Topics

Disease

17	Neoplasms (Cancer) 01/2023 - 08/2006
12	Melanoma (Melanoma, Malignant) 09/2022 - 08/2006
7	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2012
4	Multiple Myeloma 09/2011 - 01/2007
3	Uveal melanoma 01/2023 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020 - 01/2020
2	Fatigue 01/2019 - 01/2007
2	Neutropenia 04/2014 - 01/2007
1	Vesicular Stomatitis 01/2023
1	Cytokine Release Syndrome 01/2023
1	Leiomyosarcoma 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2020
1	Adenocarcinoma 01/2020
1	Leukemia 01/2019
1	Obesity 01/2019
1	Triple Negative Breast Neoplasms 04/2016
1	Hyperlipidemias (Hyperlipidemia) 08/2014
1	Nevus (Nevi) 08/2014
1	Alopecia (Baldness) 04/2014
1	Brain Neoplasms (Brain Tumor) 04/2014
1	Dyspnea (Shortness of Breath) 04/2014
1	Leukopenia 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 08/2013
1	Disease Progression 02/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2007
1	Thrombocytopenia (Thrombopenia) 01/2007
1	Exanthema (Rash) 01/2007
1	Immunoglobulin Light-chain Amyloidosis 01/2007
1	Primary Myelofibrosis (Myelosclerosis) 08/2006
1	Anemia 08/2006

Drug/Important Bio-Agent (IBA)

3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 08/2014
3	Sirolimus (Rapamycin)FDA Link 09/2020 - 08/2014
3	VaccinesIBA 01/2020 - 08/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 04/2014
3	Everolimus FDA Link 01/2018 - 08/2014
3	Lenalidomide (CC 5013)FDA Link 10/2009 - 08/2006
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2010
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023 - 08/2006
2	HhAntag691IBA 09/2020 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2012
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 12/2013
2	Capecitabine (Xeloda)FDA Link 04/2014 - 04/2012
2	pomalidomideIBA 09/2011 - 10/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2009 - 01/2007
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	olaparibIBA 01/2023
1	Interferon-betaIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AntigensIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	cabozantinibIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	Gemcitabine FDA Link 01/2020
1	Protein Subunit VaccinesIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	EmulsionsIBA 01/2020
1	glucopyranosyl lipid-AIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	EpitopesIBA 01/2019
1	resiquimodIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Cytostatic AgentsIBA 01/2018
1	IpilimumabIBA 12/2016
1	Histone Deacetylase InhibitorsIBA 04/2016
1	PanobinostatIBA 04/2016
1	Letrozole (Femara)FDA LinkGeneric 04/2016
1	Estrogen ReceptorsIBA 04/2016
1	Alkylating AgentsIBA 08/2014
1	TOR Serine-Threonine KinasesIBA 08/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	Docetaxel (Taxotere)FDA Link 12/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2013
1	thymoglobulin FDA Link 08/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2013
1	Cladribine FDA LinkGeneric 08/2013
1	AnthracyclinesIBA 12/2012
1	afliberceptIBA 12/2012
1	taxaneIBA 12/2012
1	Trastuzumab (Herceptin)FDA Link 04/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2012
1	antineoplaston A10 (A 10)IBA 02/2010
1	Immunomodulating AgentsIBA 10/2009
1	Thalidomide (Thalomid)FDA Link 10/2009
1	Interleukin-4 (Interleukin 4)IBA 07/2007
1	CytokinesIBA 07/2007
1	Hemoglobins (Hemoglobin)IBA 08/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2006

Therapy/Procedure

8	Therapeutics 12/2021 - 08/2006
4	Drug Therapy (Chemotherapy) 01/2020 - 12/2013
2	Immunotherapy 01/2019 - 08/2006
1	Lymph Node Excision (Lymph Node Dissection) 09/2022
1	Adjuvant Chemotherapy 01/2019
1	Salvage Therapy 01/2017
1	Radiotherapy 01/2016
1	Premedication 04/2014
1	Neoadjuvant Therapy 12/2013
1	Injections 08/2006